Skip to main content

Acceleris Shortlisted for The British Private Equity Awards

Acceleris Shortlisted for The British Private Equity Awards

Private Equity Awards


Seneca Partners sister company, Acceleris Capital, has been nominated for the Unquote British Private Equity Awards 2015 for the company’s work with investee company Redx Pharma.

Unquote readers and industry professionals now have the chance to have their say and vote for which firms they believe should be recognised. The poll takes place via a secure online system containing a short summary of shortlisted candidates’ successes.

Cast your votes here

Acceleris has assisted Redx Pharma and it’s predecessor through numerous funding rounds to the value of £13m under the Enterprise Investment Scheme (before the £15m IPO raise) as well as maintaining a position on the board of the company and acting as company secretary. This relationship culminated in the companies admission to the AIM market in March 2015 at a market cap of £55.2m.

Redx Pharma plc has been taken from start-up to a successful listing by Acceleris Capital and the company is now regarded as one of the leading biotechnology firms in Europe.

Redx has already established a portfolio of 13 proprietary (patent-obtected) drug programs and has been named as one of the Times Top 10 disrupters to watch since admission.


Following a recent visit by Chancellor George Osborne, the company has announced a further collaboration deal with Horizon Group plc and the share price has maintained a higher figure than on admission.

  • Voting closes this Thursday (September 10th)
  • Acceleris is nominated for Category 12: Venture Exit